At present, 70 Centers have been audited (Birmingham, Brussels, Villejuif, Barcelona, Lyon Herriot, Hambourg, Wien, Geneva, Lille, Ghent, Dublin, Budapest, Tenerife, Bergamo, Munchen, Porto, Bordeaux, Berlin, London KC, Roma, Helsinki, Rennes, Madrid Ramon y Cajal, Genova, Valencia, Sevilla, Padova, Paris-necker, Copenhagen, Warsaw, Goteborg, Innsbruck, Brussels LRLT, Essen, Lyon Herriot LRLT, Barcelona LRLT, Hannover, Izmir, Villejuif LRLT, Ghent LRLT, Berlin LRLT, Gottingen, Paris-Beaujon, Geneva LRLT, Bucharest, Palermo, Madrid 12 Octobre, Coimbra, Modena, Torino, Nice, Milano, Zurich, London KC LRLT, Paris Mondor, Mainz, Bonn, Huddinge, Roma LRLT, Wien, Istanbul, Prague, Rotterdam, Madrid Infantil, Liège, Jena, Strasbourg, Pamplona and Leuven).
The results of audit visits will be presented at the Joint International Congress of ILTS, ELITA & LICAGE, Le palais de congres de Paris, July 9-12th, 2008.

During 2006, eight papers using ELTR data were published :

 LT for Budd-Chiari syndrome. Gilles Mentha, Geneva, Switzerland (J Hepatol. 2006 Mar ;44(3):520-8)

 LT for vascular lesions. Jan Lerut, Brussels, Belgium (Ann Surg. 2006 Dec ;244(6):854-864)

 Impact of donor age and year of LT on graft and patient survival following liver transplantation for hepatitis C. Darius MIRZA, Birmingham, UK (Transplantation. 2006 Jan 15 ;81(1):7-14)

 Model for predicting survival. Andy Burroughs, London, UK (Lancet. 2006 Jan 21 ;367(9506):225-32)

 The place of liver transplantation in Caroli's disease and syndrome. De Kerckhove L, Brussels, Belgium (Transpl Int. 2006 May ;19(5):381-8)

 Liver transplant in cystic fibrosis : a poll among European centers. A study from the European Liver Transplant Registry. Melzi ML, Bergamo, Italy (Transpl Int. 2006 Sep ;19(9):726-31)

 Living liver donor mortality : where do we stand ? Bramstedt KA. (Am J Gastroenterol. 2006 Apr ;101(4):755-9)

 Documented deaths of hepatic lobe donors for living donor liver transplantation. Trotter JF. (Liver Transpl. 2006 Oct ;12(10):1485-8)

Projects of publication with ELTR data

 Thrombo-embolic complications during orthotopic LT. Robert Porte, Groningen, The Netherlands (data collection)

 Living Related LT. The European experience. René Adam, Villejuif, France (data analysis in progress)

 Retransplantation in Europe. J. Chen, Birmingham, UK (submitted for publication)

 Liver transplantation for liver secondary tumors. YP Le Treut, Marseille, France (data collection)

 European Multicenter Study on Combined Transplantation of the Liver and the Lung. M. Colledan, Bergamo, Italy (data collection)

 Outcome of patients transplanted for primary sclerosing cholangitis - Analysis of the european liver transplant registry. C. Schramm, Hamburg, Germany (data analysis in progress)

 Audit of living related liver transplantation data. A European Liver Transplant Registry study. V. Karam, Villejuif, France (data analysis in progress)

The 5th ELITA-ELTR Wintermeeting will be held in Are, Sweden from the 19th to 21st of March 2009. During this meeting lectures will be held by experts to evaluate the status of liver transplantation and its evolution.
The detailed program as well as all information necessary for registration are available on the ELITA website.

Fifty-three persons representing 18 countries participated to the 8th ELTR Workshop on December 14, 2007. The minutes of the workshop were sent to all the centers on January 21, 2008.

After the vote of participants, it has been decided to organize a workshop each two years in Paris. By consequence the 9th workshop will be held at our center on December 2009.

Workshop documents (Zip, 1.5 Mo)

Mortality following liver transplantation is dependent on both recipient and donor factors. Prof. Andrew Burroughs and Prof. Caroline Sabin from Royal Free hospital (London, UK) used ELTR data and developped risk models for 3- and 12-month mortality following liver transplantation. Both models have good validation and sufficient precision to be used to assess an individual's expected risk of mortality following transplantation, as well as to allow individual centres to directly compare outcomes from their own centre to those that would be expected based on the casemix of their transplanted population. A paper summarizing this study was published in Lancet (Lancet. 2006 Jan 21 ;367(9506):225-32).
A calculation program was also developped. Click on the following question mark to open it.

Mortality risk calculation (Zip, 474.9 ko)